Xpeng’s Hong Kong-listed shares plunged more than 12% Wednesday after the Chinese electric vehicle maker reported a wider-than-expected loss for the second quarter and weak guidance on deliveries.
On Tuesday, Xpeng reported a net loss of 2.7 billion Chinese yuan ($403.2 million), wider than the 1.6 billion yuan expected according to Refinitiv consensus estimates.
The Guangzhou, China-headquartered company also said it expects to deliver between 29,000 and 31,000 electric vehicles in the third quarter, representing a year-over-year increase of around 13% to 20.8%.
That guidance disappointed the market.
“Well the second quarter results were actually not bad at all. The revenue was even a little bit better than what we expected. And the earnings, or I should say loss, were narrower than what we expected,” Jiong Shao, analyst at Barclays, told CNBC’s “Street Signs Asia” on Wednesday.
“The problem … was really the forward Q3 delivery guidance, which is about 40% below prior estimates we had. That’s what happened to the stock price.”
Xpeng President Brian Gu said Tuesday the guidance reflects the fact that the industry is entering a “relatively slow season” and that “traffic in the stores are less than what we’ve seen before because (of the) post-COVID situation.”
In the second quarter of the year, China saw a resurgence of Covid-19. Authorities responded by locking down major cities across the country, including the financial powerhouse of Shanghai.
New models to stoke growth
Xpeng said that the G9, its new electric sports utility vehicle, is on track for its official launch next month with deliveries of the car beginning in October.
Gu said the company hopes monthly deliveries of the G9 will exceed those of its flagship P7 sedan next year. In July, Xpeng delivered 6,397 P7 vehicles.
Xpeng also plans to launch two new models in 2023.
Gu said the new cars along with the the start of deliveries for the G9, and seasonal strength in the fourth quarter, should help Xpeng grow.
“So we do think there is a strong chance and strong confidence that we are going to a growth cycle, led by our new product launches,” Gu said.
ivermectin generic – ivermectin 3 mg over the counter buy tegretol pills for sale
buy accutane 20mg – how to buy dexona order zyvox without prescription
zithromax pills – order tinidazole 300mg for sale bystolic usa
omnacortil 20mg generic – buy azipro 250mg progesterone order online
purchase gabapentin – clomipramine 25mg usa sporanox over the counter
furosemide 100mg cheap – order furosemide 40mg for sale betnovate us
order augmentin 1000mg for sale – order duloxetine order generic cymbalta
tizanidine oral – buy microzide online hydrochlorothiazide 25 mg drug
purchase sildenafil without prescription – buy cialis 5mg pills order cialis 5mg without prescription
cialis next day delivery usa – oral tadalafil 20mg order viagra online cheap
cenforce over the counter – buy generic cenforce 100mg buy glycomet 1000mg generic
buy omeprazole cheap – metoprolol where to buy tenormin 50mg generic
medrol otc – cost methylprednisolone triamcinolone ca
cytotec 200mcg pill – buy orlistat for sale buy diltiazem medication